Name | Number of supported studies | Average coverage | |
---|---|---|---|
pro-B cell | 4 studies | 42% ± 11% | |
precursor B cell | 3 studies | 30% ± 6% |
Insufficient scRNA-seq data for expression of RAG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 97% | 174.18 | 635 / 653 | 28% | 15.77 | 167 / 605 |
ovary | 26% | 1.44 | 47 / 180 | 1% | 0.01 | 3 / 430 |
kidney | 25% | 3.64 | 22 / 89 | 0% | 0 | 0 / 901 |
spleen | 23% | 1.24 | 55 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 18% | 1.02 | 47 / 258 | 3% | 0.07 | 8 / 230 |
uterus | 20% | 1.15 | 34 / 170 | 1% | 0.01 | 4 / 459 |
prostate | 13% | 0.78 | 33 / 245 | 0% | 0 | 0 / 502 |
brain | 10% | 0.58 | 264 / 2642 | 0% | 0 | 0 / 705 |
intestine | 9% | 0.48 | 90 / 966 | 0% | 0.03 | 1 / 527 |
pancreas | 6% | 0.38 | 20 / 328 | 1% | 0.07 | 1 / 178 |
stomach | 6% | 0.28 | 20 / 359 | 0% | 0.01 | 1 / 286 |
esophagus | 6% | 0.29 | 80 / 1445 | 0% | 0 | 0 / 183 |
peripheral blood | 5% | 5.81 | 47 / 929 | 0% | 0 | 0 / 0 |
lung | 5% | 0.25 | 28 / 578 | 0% | 0 | 0 / 1155 |
blood vessel | 5% | 0.24 | 64 / 1335 | 0% | 0 | 0 / 0 |
breast | 4% | 0.24 | 20 / 459 | 0% | 0.01 | 1 / 1118 |
heart | 4% | 0.19 | 36 / 861 | 0% | 0 | 0 / 0 |
liver | 3% | 0.11 | 6 / 226 | 0% | 0 | 0 / 406 |
adipose | 3% | 0.12 | 31 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
muscle | 2% | 0.13 | 19 / 803 | 0% | 0 | 0 / 0 |
skin | 2% | 0.11 | 38 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006325 | Biological process | chromatin organization |
GO_0002326 | Biological process | B cell lineage commitment |
GO_0035265 | Biological process | organ growth |
GO_0002358 | Biological process | B cell homeostatic proliferation |
GO_0002313 | Biological process | mature B cell differentiation involved in immune response |
GO_1904155 | Biological process | DN2 thymocyte differentiation |
GO_0033151 | Biological process | V(D)J recombination |
GO_0033085 | Biological process | negative regulation of T cell differentiation in thymus |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0042742 | Biological process | defense response to bacterium |
GO_0002360 | Biological process | T cell lineage commitment |
GO_0002331 | Biological process | pre-B cell allelic exclusion |
GO_0046622 | Biological process | positive regulation of organ growth |
GO_0030183 | Biological process | B cell differentiation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0097519 | Cellular component | DNA recombinase complex |
GO_0035064 | Molecular function | methylated histone binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | RAG2 |
Protein name | Recombination activating protein 2 Alternative protein RAG2 V(D)J recombination-activating protein 2 (RAG-2) V(D)J recombination-activating protein 2 |
Synonyms | |
Description | FUNCTION: Core component of the RAG complex, a multiprotein complex that mediates the DNA cleavage phase during V(D)J recombination. V(D)J recombination assembles a diverse repertoire of immunoglobulin and T-cell receptor genes in developing B and T-lymphocytes through rearrangement of different V (variable), in some cases D (diversity), and J (joining) gene segments. DNA cleavage by the RAG complex occurs in 2 steps: a first nick is introduced in the top strand immediately upstream of the heptamer, generating a 3'-hydroxyl group that can attack the phosphodiester bond on the opposite strand in a direct transesterification reaction, thereby creating 4 DNA ends: 2 hairpin coding ends and 2 blunt, 5'-phosphorylated ends. The chromatin structure plays an essential role in the V(D)J recombination reactions and the presence of histone H3 trimethylated at 'Lys-4' (H3K4me3) stimulates both the nicking and haipinning steps. The RAG complex also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. The introduction of DNA breaks by the RAG complex on one immunoglobulin allele induces ATM-dependent repositioning of the other allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. In the RAG complex, RAG2 is not the catalytic component but is required for all known catalytic activities mediated by RAG1. It probably acts as a sensor of chromatin state that recruits the RAG complex to H3K4me3 (By similarity). . |
Accessions | ENST00000529083.1 E9PQB9 L0R5C5 P55895 ENST00000529083.2 Q9BYY1 ENST00000527033.6 E9PPU5 ENST00000532616.2 ENST00000311485.8 ENST00000527033.5 |